NCT03367533View on ClinicalTrials.gov

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 29, 2018

Primary Completion Date

July 8, 2022

Study Completion Date

July 8, 2022

Conditions

Depressive Disorder, MajorPost Traumatic Stress DisorderBipolar Disorder

Interventions

DRUG

Ketamine

Intravenous ketamine

DRUG

Perampanel

Oral perampanel (6 mg)

DRUG

Placebo

Oral placebo

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors

lead

Yale University

OTHER

NCT03367533 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial | Biotech Hunter | Biotech Hunter